Top Section/Ad
Top Section/Ad
Most recent
Calendar quirk could keep issuance going in December
◆ Praemia refis at a tighter coupon ◆ Schneider lands tight at the short end ◆ Minimal concessions needed
French biotech seeks to accelerate cancer vaccine program
◆ Single digit premiums offered ◆ Reverse Yankees dominating euro supply ◆ Floaters proving popular with multi-tranche issuers
More articles/Ad
More articles/Ad
More articles
-
Ryanair completed a non-pre-emptive share placing on Thursday evening to strengthen its balance sheet to withstand the next phase of the Covid-19 pandemic and to take advantage of growth opportunities. Despite analysts not thinking the company needed extra capital, sources said the company's CEO Michael O'Leary made a compelling case to investors for the need to boost its balance sheet. -
Singaporean commodities company Mercuria has returned to the offshore loan market for its annual foray.
-
September began with a bang for equity issuance, capped off on Wednesday by a mammoth €2.7bn share sale from Siemens Healthineers. However, the rush of deals is not just being driven by optimism. Bankers fear darker days returning.
-
Siemens Healthineers, the German healthcare tech company, has sold €2.73bn of new stock in the largest block trade 2020 has seen so far to partly finance its $16.4bn acquisition of US cancer care solutions firm Varian. The consensus among ECM bankers is that it will be vital to execute transactions during the next few weeks, before a tempestuous US election and possible rises in Covid-19 cases spoil the party, write Sam Kerr and Aidan Gregory.
-
The top investment banks will achieve substantially higher returns on equity this year, predicts analytics firm Coalition, after revenues in fixed income, currencies and commodities (FICC) soared in the first half of the year.
-
WuXi Biologics Holdings has raised HK$6.1bn ($787.5m) after selling a block of shares in WuXi Biologics (Cayman), the fourth time it has trimmed its position in the company this year.
